Real-time enrollment status for this hodgkin lymphoma clinical trial
Current Status
Recruiting
Checked: September 7, 2026 at 7:09 AM UTC
| NCT Number | NCT07551583 |
| Recruiting Status | Recruiting |
| Condition | Hodgkin Lymphoma |
| Phase | PHASE2 |
| Target Enrollment | 15 participants |
| Active Locations | 1 sites in the US |
| Sponsor | M.D. Anderson Cancer Center |
| Last Updated on CT.gov | August 31, 2026 (1 week ago) |
As of September 7, 2026: Clinical trial NCT07551583 is currently recruiting participants. This phase2 study for hodgkin lymphoma is actively seeking new participants at 1 location across the United States. The study is sponsored by M.D. Anderson Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07551583 is actively recruiting participants as of September 7, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07551583 was last updated 1 week ago (August 31, 2026). HelloStudys verifies this status automatically.